U.S. Professional Services Stock News

Alvotech recently resubmitted Biologics License Applications to the U.S. FDA for AVT05, a proposed biosimilar to Simponi and Simponi Aria, and AVT06, a proposed biosimilar to Eylea 2 mg, after addressing manufacturing and quality concerns at its Reykjavik facility and responding to a recent cGMP surveillance inspection. The move, under its commercialization partnership with Teva, underscores Alvotech’s push to expand its U.S. biosimilar footprint while reinforcing upgraded quality systems...

Plexus (PLXS) is back in focus as investors react to its growing exposure to complex healthcare, life sciences, aerospace, and defense programs, a shift that is influencing expectations for margins and contract visibility. See our latest analysis for Plexus. At a share price of $273.01, the stock has eased 3.99% over the past day but still shows a 42.50% 90 day share price return and a 79.34% year to date share price return. The 1 year total shareholder return of 105.49% points to strong,...

If you are wondering whether Virtu Financial at US$52.18 is pricing in too much optimism or still offers value, the numbers behind the stock give plenty to think about. The share price has moved 4.0% over the past week, 1.7% over the last month, 60.1% year to date, and 27.6% over the past year. This raises fair questions about how much potential and risk are already reflected in the current price. Recent headlines have focused on Virtu Financial within the broader conversation around trading...

If you are wondering whether Gap's current share price really reflects what the company is worth, focusing on valuation can help you decide how the stock fits into your portfolio. Gap's stock closed at US$21.56, with the share price up 1.9% over the past week, down 7.7% over the past month, down 14.4% year to date, up 1.1% over the past year and up a very large amount over three years, while falling 19.2% over five years. Recent headlines around Gap have centered on broader retail sector...

Setting the scene for lululemon athletica (LULU) lululemon athletica (LULU) has drawn fresh attention after a prolonged share price slide, with the stock down about 13% over the past month and about 33% over the past 3 months. That pullback contrasts with the company’s latest reported fundamentals, which include annual revenue of US$11.20b and net income of US$1.46b. This has prompted investors to reassess what they are paying for future growth in the athletic apparel space. See our...

Netskope (NTSK) is back in focus after its fiscal Q1 2027 report topped the company’s own revenue guidance, yet the stock dropped sharply as investors reacted to slower net new ARR and a cautious outlook. See our latest analysis for Netskope. The sharp post earnings selloff fits into a wider reset in sentiment, with the stock down 20.6% on a 7 day share price return and 43.0% on a year to date share price return. This comes even as Netskope announced new AI security launches, expanded its...

Lockheed Martin (LMT) just combined a successful live-fire drone interception with the opening of a new missile assembly facility, giving investors fresh data points on its integrated defense technology and production capabilities. See our latest analysis for Lockheed Martin. At a share price of $523.76, Lockheed Martin has a 30 day share price return of 3.41% but is down 21.14% over 90 days. The 1 year total shareholder return of 11.67% and 5 year total shareholder return of 54.58% point to...

Recent performance snapshot Tencent Music Entertainment Group (TME) has been under pressure, with the stock down 2.4% on the day, 1.5% over the past week, and 33.9% over the past 3 months. Over the past year, the stock has declined 48.1%. The current share price is US$9.08 and the market value is about US$14.3b, with reported annual revenue of CN¥33,441 and net income of CN¥8,856. See our latest analysis for Tencent Music Entertainment Group. For context, the stock’s 1 year total shareholder...

MPLX LP recently reported first-quarter 2026 results that fell short of analyst expectations, with earnings per share at US$0.90 versus a US$1.05 consensus and total revenues of US$3.04 billion, citing higher financial costs, derivatives impacts, and increased depreciation. At the same time, MPLX underscored its growth ambitions by advancing major Permian and Marcellus infrastructure projects and completing acquisitions such as Northwind Midstream and full ownership of the BANGL NGL...

OUTFRONT Media (NYSE:OUT) has launched a private offering of US$500 million of 6.000% senior notes due 2034. The company plans to use the proceeds to redeem its outstanding senior notes due 2027 ahead of schedule. OUTFRONT Media also filed a new shelf registration to issue common stock for its employee stock ownership plan. OUTFRONT Media is an outdoor advertising company, with assets such as billboards and transit displays that connect brands with commuters and urban audiences. The fresh...

Quanex Building Products (NX) opened Q2 2026 with total revenue of US$462.4 million and basic EPS of US$0.07, while the trailing twelve months show revenue of US$1.9 billion and a basic EPS loss of US$5.65 as the stock trades around US$15.42. The company has seen quarterly revenue move from US$452.5 million in Q2 2025 to US$462.4 million in Q2 2026, with basic EPS shifting from US$0.44 to US$0.07 over the same period. This sets up a picture where top line scale contrasts with pressured...

Ralph Lauren stock snapshot after recent performance Ralph Lauren (RL) has been relatively steady in recent trading, with the stock close to its recent level of $366.55. Short term returns over the past week and month sit in low single digits. Over the past 3 months and year, total returns have been stronger, while longer multiyear figures are higher again. That backdrop gives investors context as they weigh the company’s current value score of 2. See our latest analysis for Ralph Lauren. For...

Reinsurance Group of America (NYSE:RGA) has entered into a $1.5 billion reinsurance agreement with Equitable. The deal covers $32 billion in life insurance policies, transferring a large book of risk to RGA. The transaction is expected to materially expand RGA's business footprint in life reinsurance. For investors watching NYSE:RGA, this agreement comes with the stock recently around $204.96 and multi-year returns of 50.2% over 3 years and 83.1% over 5 years. The size of the Equitable...

Why Alliance Resource Partners Stock Is Back on Investors’ Radar Alliance Resource Partners (ARLP) has drawn attention after recent trading data showed a mixed return pattern, with the stock up over the past month but down over the past 3 months. That split performance, alongside a last close of US$25.62 and a market cap of about US$3.3b, is prompting investors to reassess how the partnership’s coal operations and royalties business fit into a broader income and value-focused portfolio. See...

If you are wondering whether MannKind at around US$3.40 is a bargain or a value trap, the key question is how its current price compares with what the business might be worth. The stock has had a weak run recently, with the share price down about 9.8% over the last week, 3.4% over the past month, and 39.3% year to date, contributing to a 22.4% decline over the last year and a 16.0% fall over five years. Recent coverage has focused on MannKind's position within the broader Biotechs industry...

In early June 2026, Artisan Partners Asset Management reported preliminary assets under management of US$186.0 billion as of May 31, while broader sector rotation and concerns around redemption limits at peers stirred sentiment across alternative asset managers. This combination of firm-specific asset data and industry-wide liquidity worries has sharpened investor focus on how Artisan Partners’ business mix and expansion plans interact with market conditions. Next, we will examine how the...

Why Sanmina stock is drawing fresh attention Sanmina (SANM) is back on investor radar after a sharp single day move, with the stock falling 0.1% in the latest session but still reflecting strong longer term total returns. That combination, a modest daily decline alongside sizeable gains over the past month, past 3 months, year to date and past year, invites a closer look at what kind of company is sitting behind the recent share price action. See our latest analysis for Sanmina. Sanmina’s...

Moog stock snapshot after recent performance Moog (MOG.A) has drawn investor attention after a strong run over the past year, with the stock up about 99% on a total return basis and recent gains over the past month and past 3 months. See our latest analysis for Moog. With the share price at about $368.25, Moog has seen a 17.3% 1 month share price return and a 47.4% year to date share price return, while the 1 year total shareholder return of 99.2% and 5 year total shareholder return of 330.4%...

Mattel (NasdaqGS:MAT) is extending the Barbie movie momentum with a planned Masters of the Universe film. The company is launching a Barbie themed campaign with Dunkin' that brings the brand into food and beverage. Mattel is rolling out Mattel Brick Shop building sets, entering direct competition with established building brands and new product segments. For investors watching NasdaqGS:MAT, this cluster of moves sits at the intersection of toys, entertainment, and consumer partnerships...

If you are wondering whether Estée Lauder Companies stock is starting to look interesting on price alone, the recent mix of long term losses and shorter term gains makes it a timely moment to reassess what you are really paying for. The stock last closed at US$83.49, with the share price down 6.1% over the past week and down 3.1% over the past month, even though the 1 year return sits at 23.7% after large declines of 50.0% over 3 years and 70.0% over 5 years. These moves come as investors...

Galaxy Digital (NasdaqGS:GLXY) appears on the Fortune 500 list for the first time, marking a new level of scale and recognition for the crypto focused financial services company. Morgan Stanley Wealth Management and Galaxy Digital announce a partnership to support institutional crypto lending and access to regulated exchange traded products. The tie up is aimed at making it easier for institutional clients to move between direct crypto exposure and listed vehicles within existing wealth...

Travere Therapeutics (TVTX) is back in focus after new long term data from its Phase 3 DUPLEX Study open label extension showed sustained, clinically meaningful proteinuria reductions in focal segmental glomerulosclerosis patients on FILSPARI. See our latest analysis for Travere Therapeutics. The latest DUPLEX data and recent licensing moves have arrived after a powerful run, with Travere’s share price up 58.07% over 90 days and a 1 year total shareholder return close to 3x, although short...

Exelixis recently reported subgroup results from the phase 3 CABINET trial showing that CABOMETYX significantly improved progression-free survival versus placebo in previously treated patients with advanced neuroendocrine tumors, regardless of functional status. Because CABOMETYX already has U.S. approval for pancreatic and extra-pancreatic neuroendocrine tumors, these ASCO 2026 data mainly strengthen the drug’s clinical profile and potential real-world uptake rather than opening an entirely...

Venture Global (NYSE:VG) has issued $2.25b in senior secured notes to refinance higher interest debt. The refinancing extends debt maturities and reduces borrowing costs, targeting a stronger long term balance sheet. The transaction is positioned to support the company’s future expansion plans and capital needs. For investors watching Venture Global at a share price of $12.8, this $2.25b refinancing sits alongside a mixed recent track record. The stock is up 6.3% over the past week and...